From June 1, 2023 to June 22, 2023, the company has repurchased 245,936 shares, representing 0.88% for KRW 1,064.73 million. With this, the company has completed the repurchase of 968,118 shares, representing 3.49% for KRW 4,388.11 million under the buyback announced on June 23, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,545 KRW | +0.71% |
|
+1.87% | -13.75% |
1st Jan change | Capi. | |
---|---|---|
-13.75% | 7.05Cr | |
+25.40% | 4.55TCr | |
+34.52% | 2.45TCr | |
+27.12% | 1.65TCr | |
+21.19% | 1.47TCr | |
+71.91% | 1.43TCr | |
-0.05% | 678.76Cr | |
-11.84% | 673.29Cr | |
+18.15% | 586.92Cr | |
-8.87% | 572.55Cr |
- Stock Market
- Equities
- A004310 Stock
- News Hyundai Pharmaceutical Co., Ltd.
- Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.